Journal
TRANSPLANT INFECTIOUS DISEASE
Volume 18, Issue 4, Pages 634-636Publisher
WILEY-BLACKWELL
DOI: 10.1111/tid.12551
Keywords
hematopoietic stem cell transplantation; hematologic malignancy; cost; average wholesale price; pediatrics; respiratory syncytial virus
Categories
Funding
- Gilead
- Ansun Biopharma
- ADMA Biologics
- Glaxo-Smith and Kline
- Gilead Sciences
Ask authors/readers for more resources
Dramatic, overnight cost increases of important orphan and generic medications have recently come under public and government scrutiny. We highlight the case of aerosolized ribavirin, an important antiviral agent in hematopoietic stem cell transplantation which, because of substantial price increases, may now cost more than the transplant procedure itself.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available